# A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis

> **NCT02424253** · PHASE2 · COMPLETED · sponsor: **Ziarco Pharma Ltd** · enrollment: 98 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** ZPL-3893787
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02424253
- **Lead sponsor:** Ziarco Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-18
- **Primary completion:** 2016-01
- **Final completion:** 2016-02-03
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2021-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02424253

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02424253, "A Study to Determine the Efficacy of ZPL-3893787 in Subjects With Atopic Dermatitis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02424253. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*